Search results
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in...
NBC 17 Raleigh· 7 days agoUpon the execution of the agreement, Hanmi Pharmaceutical will conduct a phase 1 clinical trial to evaluate the safety and efficacy of its immuno-oncology drug, 'BH3120', in combination with ...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 5 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 18 hours ago- BeyondSpring Dosed First Patient of Two Phase 2 Investigator-Initiated Trials (IIT) in Plinabulin and Keytruda Combination Studies - SITC 2023 Presentation of the Phase ...
British patients test world’s first personalised MRNA cancer jab for melanoma
The Independent via Yahoo News· 5 days agoPhase 2 trial data, published in December, found that people with serious high-risk melanomas who...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 5 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Morningstar· 6 days agoMedia Release Data from efti in combination with KEYTRUDA® in first line head and neck squamous cell carcinoma patients who do not express PD-L1 (TACTI-003, Cohort B) shows ...
British man tests first personalised melanoma vaccine
BBC via Yahoo News· 5 days agoPhase II trial data, published in December, found that people with serious high-risk melanomas who...
Man’s ‘bump on head’ turns out to be sign of skin cancer
Yahoo Life UK· 4 days agoYoung says he feels 'excited' to be trialling the new vaccine. (PA) PA Phase 2 data, published in...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 5 days agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
U.K. Tests World-First Personalized Skin Cancer Vaccine
Forbes· 4 days agoBritish patients are trying a first-of-its-kind customized vaccine for skin cancer as part of a...